Navigation Links
Codexis Reports Fourth Quarter and Full Year 2010 Results
Date:2/3/2011

REDWOOD CITY, Calif., Feb. 3, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced financial results for the fourth quarter and year ended December 31, 2010.  

Full Year 2010 Financial Highlights:Revenue:  Revenue increased 29% to $107.1 million, driven by a 77% increase in sales of pharmaceutical products, from $18.6 million in 2009 to $32.8 million in 2010, and increases in collaborative R&D and government grants.

Operating Expenses:  Full year operating expenses increased 2% to $86.2 million.  R&D expenses decreased 4% to $52.4 million, primarily from the elimination of royalty payments to Maxygen, Inc. as a result of our acquisition of Maxygen's gene shuffling IP portfolio in October, 2010.  SG&A expenses increased 13% to $33.8 million driven by increases in compensation and benefits and outside services costs associated with becoming a public company.

Net Loss:  Net loss was ($8.5) million, or ($0.35) per share, based on 24.6 million weighted average common shares outstanding for the full year 2010.   This compares to a net loss of ($20.3) million in 2009.  

Adjusted EBITDA:  On a non-GAAP basis, Adjusted EBITDA was $9.9 million compared to a loss of ($7.3) million in 2009. Adjusted EBITDA is calculated by adjusting net loss for net interest expense, income taxes, depreciation, amortization, stock-based compensation and preferred stock warrant fair market valuation.  A reconciliation of net loss to Adjusted EBITDA is presented below.

Fourth Quarter Financial Highlights:Revenue: For the fourth quarter of 2010, the company reported revenues of $29.8 million, an increase of 23% from $24.2 million in the fourth quarter of 2009, primarily due to an increase of $3.4 million in product revenue, representing an increase of 67% over the same time period of 2009.


'/>"/>

SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Codexis Grows Revenue 35 Percent in Third Quarter; Raises 2010 Outlook
2. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
3. Codexis R&D Productivity Panels Also Used By Roche
4. Codexis Names Lori Giver VP Systems Biology
5. Codexis, Teva in Licensing Agreement Final
6. Codexis Names Vice President, Intellectual Property
7. Codexis, Arch Announce Expanded Collaboration
8. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
9. Kensey Nash Reports Second Quarter Fiscal Year 2011 Financial Results
10. PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results
11. Haemonetics Reports Third Quarter of Fiscal 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Proove Biosciences , the commercial ... announce a new genetic test built upon research from ... Test will provide physicians with an objective way ... levels are stratified between individuals. With this new test, ... has a genetic predisposition that will affect their pain ...
(Date:9/30/2014)... Switzerland (PRWEB) September 30, 2014 ... software solutions for drug discovery and related ... FUNGITECT consortium has chosen Genedata Selector as ... sequencing (NGS) data. FUNGITECT is a European ... invasive fungal diseases via individualized anti-fungal drug ...
(Date:9/30/2014)... 30, 2014 iLab Solutions announced the ... study which focuses on core facility operations, growth ... managers face today. , In its 4th year running, ... note is the year-over-year decrease in the percentage of ... to be feeling the constraints of this trend. When ...
(Date:9/30/2014)... 2014 Rainbow Scientific, Inc. (RSI), ... recently opened an online store to add customer ... lines developed and manufactured by Biological Industries, Inc. ... Biological Industries’ Nutristem® serum-free, xeno-free reagents for human ... cell (hESC) culture. , The online store ...
Breaking Biology Technology:Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3Rainbow Scientific, Inc. opens online store for state-of-the-art stem cell culture and cytogenetic reagents 2
... ), focused on discovering, developing and,commercializing treatments for diabetes and ... -- 18th Annual Wachovia Nantucket Equity Conference on Monday, ... (Eastern Time) at The White Elephant in Nantucket ... Conference on Thursday, June 26, 2008 ...
... and Advance,Healthcare, WASHINGTON, June 16 The ... Act (HIPAA) is having a,negative impact on the ... that benefit society, says a newly-released report by ... Barriers to,Research and Discovery describes the unintended disruptive ...
... ROCKVILLE, Md., June 16 Novavax, Inc.,(Nasdaq: NVAX ... Singhvi, President and Chief Executive Officer, will be presenting ... on June 24, 2008 at,The ANdAZ Hotel in London, ... strategy, research and development progress. A link to the ...
Cached Biology Technology:HIPAA Privacy Rule Impedes Biomedical Research 2
(Date:9/30/2014)... Fish can live in almost any aquatic environment on ... up many species are pushed to the limit. The ... could prove critical for how different species cope in ... the University of Gothenburg, published in the scientific journal ... Climate change continues apace thanks to increasing levels of ...
(Date:9/30/2014)... it comes to using marijuana, new research, involving mice ... Journal of Leukocyte Biology , suggests ... that you should. That,s because a team of Italian ... do serious long-term damage to the immune system. This ... diseases, such as multiple sclerosis, inflammatory bowel disease and ...
(Date:9/30/2014)... trouble getting pregnanteven with IVF? Here,s some hope: A ... The FASEB Journal , explains how ... known as PAWP, which induced embryo development in human ... embryo development by the sperm cell during fertilization. , ... a major paradigm shift in our understanding of human ...
Breaking Biology News(10 mins):Shape up quickly -- applies to fish, too! 2Adolescent exposure to thc may cause immune systems to go up in smoke 2Synthetic sperm protein raises the chance for successful in vitro fertilization 2
... and terrorist attacks may bring about profound spiritual ... for people that have experienced or witnessed these ... mental disorder caused by psychological trauma is termed ... damage alter as symptoms improve? As PTSD progresses, ...
... just published research that will help you every morning ... Vice-Chancellor will allow oceanographers and meteorologists to better predict ... as they travel across the globe. "Ocean cargo ... activities such as surfing, are all dependent on wave ...
... recently awarded a $449,641 grant by the Institute of Museum ... crowd sourcing and gaming to support the enhancement of texts ... December 2013 and ends in December 2015. The Garden will ... Botanical Garden on the project. , The BHL is ...
Cached Biology News:VC predicts the motion of the ocean 2Missouri Botanical Garden aims to improve access to digital texts through online gaming 2
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
...
Tube-O-DIALYZER Floats, small....
Biology Products: